ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001642355

Braslyn Ltd.

CIK 0001642355 Name as filed on the most recent filing

Filed as Braslyn Ltd. (18)

64 transaction lines · from 18 filings · filed 2016-03-22 to 2021-03-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

27 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2021-03-10 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 200 disposed 198.00 39,600.00 Form 4, filing 0000899243-21-011086
2021-03-10 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 189 disposed 195.52 36,953.28 Form 4, filing 0000899243-21-011086
2021-03-10 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 20 disposed 196.12 3,922.40 Form 4, filing 0000899243-21-011086
2021-03-10 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1 disposed 195.90 195.90 Form 4, filing 0000899243-21-011086
2021-03-09 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4,633 disposed 197.30 914,090.90 Form 4, filing 0000899243-21-011086
2021-03-09 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 3,993 disposed 197.81 789,855.33 Form 4, filing 0000899243-21-011086
2021-03-09 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 2,237 disposed 199.08 445,341.96 Form 4, filing 0000899243-21-011086
2021-03-09 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,107 disposed 195.82 216,772.74 Form 4, filing 0000899243-21-011086
2021-03-09 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1 disposed 191.00 191.00 Form 4, filing 0000899243-21-011086
2020-12-16 Inseego Corp.
INSG 		S, Open-market sale 293,848 disposed 14.37 4,224,035.62 Form 4, filing 0000899243-20-034137
2020-12-15 Inseego Corp.
INSG 		S, Open-market sale 190,590 disposed 14.81 2,822,199.54 Form 4, filing 0000899243-20-034137
2020-12-14 Inseego Corp.
INSG 		S, Open-market sale 1,721,783 disposed 15.62 26,891,667.79 Form 4, filing 0000899243-20-034137
2020-12-14 Inseego Corp.
INSG 		S, Open-market sale 178,949 disposed 16.07 2,875,710.43 Form 4, filing 0000899243-20-034137
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 27,992 disposed 215.08 6,020,396.20 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 15,091 disposed 209.66 3,163,970.01 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 14,408 disposed 211.50 3,047,339.55 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 11,656 disposed 216.06 2,518,338.25 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 10,599 disposed 210.58 2,231,944.84 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 6,775 disposed 217.14 1,471,156.70 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 5,912 disposed 218.04 1,289,025.28 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 3,108 disposed 212.66 660,946.66 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 2,344 disposed 214.31 502,335.37 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,674 disposed 208.78 349,497.89 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,088 disposed 206.50 224,670.91 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,086 disposed 207.96 225,849.23 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 818 disposed 220.02 179,979.63 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 800 disposed 205.64 164,515.84 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 663 disposed 218.85 145,097.55 Form 4, filing 0000899243-20-030059
2020-10-29 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 550 disposed 203.32 111,827.54 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 45,896 disposed 205.49 9,431,169.04 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 44,959 disposed 203.35 9,142,322.73 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 41,266 disposed 206.50 8,521,429.00 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 38,543 disposed 204.57 7,884,741.51 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 38,525 disposed 207.35 7,988,158.75 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 37,428 disposed 209.47 7,840,043.16 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 25,036 disposed 208.40 5,217,502.40 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 23,283 disposed 210.31 4,896,647.73 Form 4, filing 0000899243-20-030059
2020-10-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 500 disposed 211.06 105,531.50 Form 4, filing 0000899243-20-030059
2020-07-21 Pandion Therapeutics, Inc.
PAND 		P, Open-market purchase 722,222 acquired 18.00 12,999,996.00 Form 4, filing 0000899243-20-019894
2020-06-12 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 600,000 disposed 97.00 58,200,000.00 Form 4, filing 0000899243-20-016700
2020-06-12 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 600,000 disposed 69.00 41,400,000.00 Form 4, filing 0000899243-20-016664
2019-03-01 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 275,000 disposed 69.00 18,975,000.00 Form 4, filing 0000899243-19-006351
2017-11-16 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 255,264 acquired 13.00 3,318,432.00 Form 4, filing 0000899243-17-026986
2017-11-16 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 144,736 acquired 13.00 1,881,568.00 Form 4, filing 0000899243-17-026986
2017-01-26 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 28,839 acquired 5.45 157,172.55 Form 4, filing 0000899243-17-002188
2017-01-26 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 19,330 acquired 5.44 105,155.20 Form 4, filing 0000899243-17-002188
2017-01-25 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 30,600 acquired 5.42 165,852.00 Form 4, filing 0000899243-17-001947
2017-01-24 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 27,682 acquired 5.32 147,268.24 Form 4, filing 0000899243-17-001947
2017-01-23 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 19,251 acquired 5.27 101,452.77 Form 4, filing 0000899243-17-001947
2017-01-20 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 23,873 acquired 5.42 129,391.66 Form 4, filing 0000899243-17-001652

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 20
  • Open-market sale 7
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Braslyn Ltd., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001642355

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.